Michael Schenker
Michael Schenker publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Colorectal Cancer Treatments and Studies.
- World rank
- #139,264 of 7,710,434 ranked researchers
- Rank in Romania
- #62 of 26,789
- Works
- 285
- Citations
- 19k
- Citations per work
- 68.0
What does Michael Schenker research?
Michael Schenker's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences19668.8%
- Medicine19668.8%
- Everything else6322.0%
- Life Sciences269.2%
- 1Oncology38% of their works
- 2Pulmonary and Respiratory Medicine17% of their works
- 3Surgery11% of their works
- 4Molecular Biology6% of their works
- 5Epidemiology4% of their works
- 6Cancer Research3% of their works
Research topics
Which keywords describe Michael Schenker's research?
The keywords of their largest research topics: Immune Checkpoint Blockade, PD-1 and PD-L1, Chemotherapy, Clinical Trials, Targeted Therapy, Immunotherapy, ALK Inhibitors and EGFR Mutations.
- CAR T Cells
- Bladder Cancer
- Esophageal Carcinoma
- Gastric Cancer
- Genomic Profiles
- Cetuximab
- Molecular Characterization
- EGFR Mutations
- Immunotherapy
- Clinical Trials
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Chemotherapy
- Targeted Therapy
- ALK Inhibitors
- Endoscopic Resection
- Neoadjuvant Therapy
- KRAS Mutations
- Small-Cell Lung Cancer
- Lymph Node Dissection
- Preoperative Chemoradiotherapy
- Urothelial Carcinoma
- Chimeric Antigen Receptor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Immune Checkpoint Blockade1261 topic
- PD-1 and PD-L11261 topic
- Chemotherapy974 topics
- Clinical Trials752 topics
- Targeted Therapy752 topics
- Immunotherapy643 topics
- ALK Inhibitors481 topic
- EGFR Mutations481 topic
- Endoscopic Resection432 topics
- Molecular Characterization422 topics
- Neoadjuvant Therapy412 topics
- Cetuximab281 topic
- KRAS Mutations281 topic
- Genomic Profiles271 topic
- Small-Cell Lung Cancer271 topic
- Gastric Cancer221 topic
- Lymph Node Dissection221 topic
- Esophageal Carcinoma211 topic
- Preoperative Chemoradiotherapy211 topic
- Bladder Cancer201 topic
- Urothelial Carcinoma201 topic
- CAR T Cells171 topic
- Chimeric Antigen Receptor171 topic
Where does Michael Schenker work?
Michael Schenker's main affiliation in the publication record is University of Medicine and Pharmacy of Craiova, Romania.
How many publications and citations does Michael Schenker have?
OpenAlex counts 285 works and 19,369 citations for Michael Schenker, an h-index of 48, ranking #139,264 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Schenker. Posts are plain text and can be reported.